Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 564

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 564
---
5, were as follows:

| Maturity of Lease Liabilities            |     | Operating 
    Leases |
| 2025                                     |     |      $425 |
| 2026                                     |     |       665 |
| 2027                                     |     |       685 |
| 2028                                     |     |       705 |
| 2029                                     |     |       726 |
| 2030 and beyond                          |     |     1,583 |
| Total future undiscounted lease payments |     |     4,789 |
| Less: imputed interest                   |     |    -1,199 |
| Total reported lease liability           |     |    $3,590 |

8. Income Taxes Our effective tax rate may vary from the U.S. federal statutory tax rate due to the valuation allowance. The effective tax rate for the three months ended March 31, 2025 and 2024 was zero and 1%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March 31, 2025 and 2024 was primarily due to valuation allowance. Note 9: Relationship with Parent and Related Entities Historically, the Company’s business has been managed and operated in the normal course of business consistent with other affiliates of the Parent. Accordingly, certain shared costs have been allocated to the Company and reflected as expenses in its condensed financial statements. Management considers the allocation methodologies used to be reasonable and appropriate reflections of the historical Parent expenses attributable to the Company for purposes of its stand-alone condensed financial statements. However, the expenses reflected in the condensed financial statements may not be indicative of the actual expenses that would have been incurred during the periods presented if the Company historically operated as a separate, stand-alone entity. In addition, the expenses reflected in the condensed financial statements may not be indicative of related expenses that will be incurred in the future by the Company. The condensed statements of operations include expenses for certain centralized functions (such as accounting, treasury, audit, purchasing, human resources, legal and facilities), executive compensation and other programs provided and/or administered by Parent that are charged directly to the Company. A portion of these costs benefits the Company and is allocated using a pro-rata method based on measures that management believes are consistent and reasonable.

F-64

TABLE OF CONTENTS

The amounts of corporate expenses allocated to the Company are summarized in a table below:

|                                                   |     | Three months ended 
          March 31, |